AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MARECHALE CAPITAL PLC

Earnings Release Dec 17, 2013

7775_ir_2013-12-17_6e9d27f5-26bd-4933-b80d-667fb36935e5.html

Earnings Release

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6792V

Marechale Capital PLC

17 December 2013

17 December 2013

Marechale Capital plc

("Marechale Capital" or the "Company")

Interim Results

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2013.

Chairman's Statement

I am pleased to report that Marechale has made a very good start to the current year. On the back of improving economic sentiment, and more confidence in the equity markets, the Company's revenues are significantly ahead of where they were this time last year at £433,924 (2012 £140,682), an increase of  208%, and we are able to report that we have made a small profit of £18,915 (2012 loss £156,044) for the half year.

Marechale is acting for an increasing number of growth companies, and has successfully completed a series of transactions, which are all detailed on the Company's website at: www.marechalecapital.com. During the last six months a number of transactions that were started, in some cases, many months ago, have been completed, as well as more recently mandated business.

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies in two primary sectors in which the team have a long term track record; Leisure and Retail, and Renewable Energy.

Marechale helps management teams to finance or refinance in two key areas of activity; Growth Capital private equity transactions for more established businesses, and Development Capital, fundraising for smaller growth companies, the latter typically being Enterprise Investment Scheme (EIS) qualifying. As part of Marechale's success fee, the Company secures warrants or equity on most of its projects, so shareholders have the opportunity to share in the potential significant upside of the equity value in these businesses. These investments are valued at cost or at a price that reflects their last funding round. The Board expects these to grow in value over the next few years.

One of the Company's initiatives in the renewables sector which we are pleased to provide an update on is the development of ultra large scale solar energy sites in the UK, through Marechale's joint venture company, Northfield UK Solar Limited (Northfield). Established in July this year, and first referred to in our last annual report and accounts, Northfield is developing a portfolio of solar sites; currently, it has signed exclusivity on approximately 350MW of large scale solar sites in the UK, on which it is aiming to secure grid connection offers and planning permission over the next few years. This is one of the larger solar energy initiatives in the UK, and, whilst it is difficult to attribute values until planning permissions and grid connections for the various sites have been secured, there is significant potential uplift value for Marechale's shareholders. The current fund raising round is in its final stages and is close to completing and, assuming that it achieves the maximum funding, Marechale's stake in Northfield will be around 28% of the enlarged equity, and would be Marechale's largest investment to date. This would be a post balance sheet item that is not reflected in these interim accounts.

In addition, Marechale completed the first stage funding of its anaerobic digestion EIS fund, which has been deployed to develop a 2MW AD plant in Norfolk. This is the fifth plant that Marechale's client, Future Biogas, has now built.

In other areas, the Company successfully completed a number of leisure deals, including the £10m equity and debt funding for Inn Collection, further endorsing Marechale's leading position in funding businesses in the leisure sector.

Whilst market conditions are still challenging, we are now more optimistic about the immediate outlook; there is also a healthy pipeline of new business that is being generated. Deal flow is picking up and, at our current level of 10, we have our largest number of engaged corporate finance projects to date. The year end results to March 2014 will be dependent on their outcome and whether the projects are completed before the year end.

There is an appetite amongst our investor relationships to invest in high quality investment opportunities. The Directors believe that backing the right growth companies, whilst not without its risks, represents an interesting private equity investment class for investors looking to diversify their portfolios. Over the last three and half years, if an investor had invested in each one of the 14 transactions Marechale has funded and completed, based on the last round of funding or exit value of these transactions, we calculate that they would have achieved an IRR of over 38% to date.

We will announce our full year's results in the summer of 2014.

Mark Warde-Norbury

Chairman

17 December 2013

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn
Tel: +44 (0)20 7628 5582
Smith & Williamson Corporate Finance

Azhic Basirov / David Jones
Tel: +44 (0)20 7131 4000
Marechale Capital plc
Income Statement (unaudited)
Six months ended 30 September 2013
30 Sept 30 Sept
2013 2012
£ £
Revenue 433,924 140,682
Cost of sales (167,741) (32,211)
Gross profit 266,183 108,471
Administrative expenses (260,711) (278,015)
Operating profit/(loss) 5,472 (169,544)
Investment revenues 1,735 0
Other gains and losses 11,708 13,500
Profit/(loss) before tax 18,915 (156,044)
Corporation tax charge 0 0
Profit/(loss)  for the period 18,915 (156,044)
Earnings per share (Basic and diluted)

57,681,151 shares (2012: 52,437,410)
0.04p (0.30p)
Balance Sheet (unaudited)
As at 30 September 2013
30 Sept 30 Sept
2013 2012
£ £
Current assets
Available for sale investments 124,384 101,238
Trading investments 67,555 1,600
Trade and other receivables 214,306 129,176
Cash and cash equivalents 238,784 147,715
Total current assets 645,029 379,729
Current liabilities
Trade and other payables (65,435) (53,721)
Corporation tax 0 0
Total current liabilities (65,435) (53,721)
Net assets 579,594 326,007
Equity
Share capital 2,474,308 2,421,871
Share premium account 1,247,379 1,227,452
Revaluation reserves 39,635 16,989
Other reserves (50,254) (50,254)
Retained earnings (3,131,474) (3,290,051)
Total equity 579,594 326,007
Cash Flow Statement (unaudited)
Six months ended 30 September 2013
30 Sept 30 Sept
2013 2011
£ £
Net cash from operating activities
Operating profit /(loss) 5,473 (169,544)
Operating cash flows before movements in working capital 5,473 (169,544)
Movement in working capital
(Increase)/decrease in receivables (21,742) 22,918
(Decrease)in payables (20,607) (908)
(42,349) 22,010
Operating cash flow (36,876) (147,534)
Investment activities
Interest receivable 1,734 0
Proceeds on disposal of trading investments 0 20,000
Proceeds on disposal of available for sale investments 11,708 (500)
Expenditure on tangible fixed assets 0 0
Expenditure on trading investments 0 (35,000)
Cash flow from investing activities 13,442 (15,500)
Financing
Issue of share capital 0 0
Interest payable 0 0
Cash flow from financing activities 0 0
Net increase/(decrease) in cash and cash equivalents (23,434) (163,034)
Cash and cash equivalents at start of period 262,218 310,749
Cash and cash equivalents at end of period 238,784 147,715
(Decrease)/ increase in cash and cash equivalents (23,434) (163,034)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods being reported on the same basis.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR NKADPABDDCBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.